Page last updated: 2024-11-07

tyrosinamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

tyrosinamide: RN given refers to (S)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

L-tyrosinamide : An amino acid amide that is L-tyrosine in which the carboxy OH group is replaced by NH2. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID151243
CHEBI ID21412
SCHEMBL ID358908
MeSH IDM0110896

Synonyms (34)

Synonym
4985-46-0
AC-13399
l-tyrosinamide
DB03380
tyrosine amide
(2s)-2-amino-3-(4-hydroxyphenyl)propanamide
tyrosinamide
l-tyrosine amide
TYC ,
AKOS005067895
unii-05lu01cs4t
benzenepropanamide, alpha-amino-4-hydroxy-, (s)-
05lu01cs4t ,
h-tyr-nh2
BP-12563
l-tyr-nh2
CHEBI:21412
AM82347
(s)-2-amino-3-(4-hydoxyphenyl)propanamide
tyrn
tyrosinamide, l-
amidated l-tyrosine
benzenepropanamide, .alpha.-amino-4-hydroxy-, (.alpha.s)-
tyrosine imine
SCHEMBL358908
(s)-2-amino-3-(4-hydroxyphenyl)propanamide
CS-W008559
DTXSID70198120
Q27094319
STR05440
D83107
A871706
EN300-881789
Z760046828
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
amino acid amideAn amide of an amino acid formed formally by conversion of the carboxy group to a carboxamido group.
L-tyrosine derivativeA proteinogenic amino acid derivative resulting from reaction of L-tyrosine at the amino group or the carboxy group, or from the replacement of any hydrogen of L-tyrosine by a heteroatom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (38)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (10.53)18.7374
1990's11 (28.95)18.2507
2000's9 (23.68)29.6817
2010's12 (31.58)24.3611
2020's2 (5.26)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 25.18

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index25.18 (24.57)
Research Supply Index3.71 (2.92)
Research Growth Index4.82 (4.65)
Search Engine Demand Index30.00 (26.88)
Search Engine Supply Index3.09 (0.95)

This Compound (25.18)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (5.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other38 (95.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]